Concepedia

The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study

Florence Van Obbergh, Laurent Knoops, Timothy Devos, Yves Béguin, Carlos Graux, Fleur Samantha Benghiat, Khalil Kargar-Samani, Deborah Bauwens, André Efira, Christian Dubois,

Clinical Biochemistry · 2016 · 17 citations · 8 references

DOIFull text

Open access

Concepts

References

8

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 38.7K citations

, , +21

Evaluation of survival data and two new rank order statistics arising in its consideration.

Nathan Mantel · PubMed · 1966 · 7.6K citations

, , +7

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

Richard A. Larson, Brian Druker, François Guilhot et al. · Blood · 2008 · 631 citations · Full text

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study

Lucien Noens, Marie-Anne van Lierde, R. De Bock et al. · Blood · 2009 · 606 citations · Full text

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

Stéphane Picard, Karine Titier, Gabriel Étienne et al. · Blood · 2006 · 604 citations · Full text